| 1 |
Partly verified |
Full text not readStored summary read |
N01 · Comparative efficacyAre the original PC PhenoAge and PC GrimAge claim and subclaim assessment separated from the parent slowing context?Required |
The original subclaim is 'Reduced PC PhenoAge and PC GrimAge', with grade D and a note that neither measure changed significantly. The parent overall assessment, including DunedinPACE, is C54 with Unknown safety. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. The subclaim has no score, status or axes; parent values are not used to fill them. No new assessment is made. |
Records of the subclaim's original wording, grade and note and the parent context |
Connect additional original material for each measure separately to the subclaim question and parent context. |
| 2 |
Partly verified |
Full text not readStored summary read |
N02 · Comparative efficacyDo the two PC measures concern healthy non-obese adults?Required |
The original paper is a post hoc analysis of 220 healthy non-obese adults in CALERIE at three US sites. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. Findings are not automatically extended to direct effects in aging-related disease, obesity, other ages or frail populations. Detailed eligibility and baseline values have not been read. |
Eligibility, baseline condition, age, BMI and group denominators |
Obtain original population and baseline characteristics and numbers analyzed for each measure. |
| 3 |
Partly verified |
Full text not readStored summary read |
N03 · Comparative efficacyAre the 25% target and about 12% achieved restriction distinguished as study exposures?Required |
The original target is recorded as 25%, with average achieved restriction of about 12%. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. These are historical study conditions rather than personal calorie or weight-loss targets. The two PC findings are not assumed to be effects of the target exposure. |
Original plans, achieved restriction, duration, adherence and measurements |
Obtain original exposure measurements, individual adherence, restriction achieved over time and support records. |
| 4 |
Partly verified |
Full text not readStored summary read |
N04 · Comparative efficacyIs the actual comparison of control diets, support and concurrent changes available?Required |
The parent's randomized two-year caloric-restriction context is preserved. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. Detailed control diets, exposures, contact and support are absent from the original summary. Equivalent nutrient composition or weight changes are not invented. |
Actual diets, contact, support and concurrent management by group |
Obtain original intervention, control, support, achieved-exposure and concurrent-change material. |
| 5 |
Partly verified |
Full text not readStored summary read |
N05 · Comparative efficacyAre 220 randomized participants and the 197-person DNA analysis time-specific PC denominators?Required |
There were 220 participants randomized 2:1; the DNA analysis included 197 participants with baseline and at least one follow-up sample. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. Group sizes are not calculated from 2:1 allocation. The 197 participants are not assumed to be the denominator for all PC outcomes at 12 or 24 months. |
Group allocation, DNA samples and analysis denominators by measure and time |
Obtain group samples and analysis flows and denominators by time and measure. |
| 6 |
Partly verified |
Full text not readStored summary read |
N06 · Comparative efficacyAre gaps in DNA sample selection, missingness, follow-up and models preserved?Required |
The original account requires baseline and at least one follow-up sample for DNA inclusion. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. Group exclusions, time-specific missingness, ITT, data processing and sensitivity analyses have not been read. New attrition rates or differences are not calculated. |
Missingness, selection, analysis populations, sensitivity analyses and models by measure |
Obtain original DNA selection, missingness, models and sensitivity material. |
| 7 |
Partly verified |
Full text not readStored summary read |
N07 · Comparative efficacyAre the definition, units and original individual effects of PC PhenoAge directly available?Required |
PC PhenoAge is one of the three original measures and is recorded as not significantly changed. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. The endpoints of the d −0.04 to 0.05 range in the original rationale are not assigned as a particular time-specific PC PhenoAge effect. Individual CIs, P values and unit details have not been read. |
Definitions, units, time points, denominators, effects and intervals for individual measures |
Obtain original PC PhenoAge definitions, effects, CIs, P values and denominators by time. |
| 8 |
Partly verified |
Full text not readStored summary read |
N08 · Comparative efficacyAre the definition, units and original individual effects of PC GrimAge directly available?Required |
PC GrimAge is also one of the three original measures and is recorded as not significantly changed. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. The endpoints of the d range are not assigned as a particular PC GrimAge effect. Individual CIs, P values, denominators and algorithm definitions have not been read. |
Definitions, units, time points, denominators, effects and intervals for individual measures |
Obtain original PC GrimAge definitions, effects, CIs, P values and denominators by time. |
| 9 |
Partly verified |
Full text not readStored summary read |
N09 · Comparative efficacyAre the d range and P threshold presented jointly for the two measures distinguished from individual values?Required |
The original account describes the two PC measures as null, with d −0.04 to 0.05 and P>0.15. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. The range is not converted into a new mean, point estimates for each measure, exact P values or CIs. Zero effects or equivalence are not certified. |
Detailed tables of original effects, intervals and tests by measure and time |
Obtain original tables of individual effects, CIs, tests, models and denominators. |
| 10 |
Unverified |
Full text not readStored summary read |
N10 · Comparative efficacyAre PC outcomes at 12 and 24 months preserved separately by time?Required |
The original rationale gives DunedinPACE results at 12 and 24 months specifically, but describes the two PC measures as null only within a summary range. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. Time-specific DunedinPACE d values, CIs and P values are not copied as PC values. Individual time-specific PC values remain unverified. |
PC values, changes, between-group effects and denominators at each time |
Obtain original tables and analysis denominators for both PC measures at each time. |
| 11 |
Partly verified |
Full text not readStored summary read |
N11 · Comparative efficacyHas the positive DunedinPACE signal been kept separate from PC reductions?Required |
The original DunedinPACE signal is preserved: d=−0.29 (95% CI −0.45 to −0.13) at 12 months, d=−0.25 (−0.41 to −0.09) at 24 months, original P<0.003 and roughly 2~3% slowing. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. This measure's slowing is not used to fill in reductions in PC PhenoAge or PC GrimAge. A 24-month CI level or individual P values are not newly added. |
Results, units, time points and direct original effects by measure |
Connect original effects, intervals, time points and models separately by measure. |
| 12 |
Partly verified |
Full text not readStored summary read |
N12 · Comparative efficacyDo the PC age measures and DunedinPACE pace measure quantify the same thing?Required |
The original account separates three DNA-methylation clocks or measures and describes DunedinPACE as a surrogate pace-of-aging measure. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. Pace changes, PC reductions and clinical aging itself are not combined as the same value. Exact measure-specific definitions, units and validation have not been read. |
Purpose, definitions, units, validation and applicability of each measure |
Obtain original methods, units and validation material separately for each measure. |
| 13 |
Unverified |
Full text not readStored summary read |
N13 · Comparative efficacyAre DNA laboratory methods, batches, normalization and PC calculation directly preserved?Required |
The design is a post hoc DNA-methylation analysis; the original account records laboratory analyst blinding. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. PC algorithm, measurement, batch and normalization details are not invented, and new PC scores are not calculated from original data. |
Original methods for samples, platforms, batches, normalization and PC calculation |
Obtain original laboratory, measure-calculation and data-processing methods. |
| 14 |
Partly verified |
Full text not readStored summary read |
N14 · Comparative efficacyAre the post hoc analysis and the parent's prespecified clinical primary plan separated?Required |
The paper is explicitly post hoc, and the original account states that this was not the parent's prespecified clinical primary endpoint. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. The two PC measures are not newly designated as prespecified clinical coprimary endpoints. Registration and SAP remain unread in this production. |
Original registration, protocol, SAP, analysis selection, changes and hierarchy |
Obtain parent plans and records of post hoc measure selection, hierarchy and changes. |
| 15 |
Partly verified |
Full text not readStored summary read |
N15 · Comparative efficacyAre the split findings across three key measures and plans for multiple time points and tests preserved?Required |
The original assessment that only one of three measures was positive and the parent's split-key-measures flag set to true are preserved. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. The original split-results axis is not converted into a prespecified clinical primary designation. Adjustments for nonsignificant PC findings or positive DunedinPACE findings are not invented. |
Original plans for three measures, time points, effects of interest, multiplicity and selective reporting |
Obtain tests and adjustments by measure and time, original outcome lists and selective-reporting records. |
| 16 |
Partly verified |
Full text not readStored summary read |
N16 · Comparative efficacyAre null or nonsignificant findings distinguished from exclusion of a clinically important effect or equivalence?Required |
The original account states that there was no clinical minimum-effect threshold or prespecified success boundary and records null findings for both PC measures. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. P>0.15 without individual CIs does not newly certify exclusion of all meaningful reductions or equivalence. |
Individual CIs, validated thresholds and prespecified success boundaries |
Obtain original CIs, clinical-importance validation and prespecified plans for each PC measure. |
| 17 |
Partly verified |
Full text not readStored summary read |
N17 · Comparative efficacyAre blinding and allocation procedures recorded at their actual measure-specific scope?Required |
The original Korean account says analysts were unaware of allocation; the English account specifies 'laboratory analysts blinded'. The 2:1 randomized design is preserved. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. Participant, intervention-provider or all-analyst blinding and allocation concealment are not described as newly verified. |
Parent allocation, laboratory analysts, statistical analysis and measurement methods |
Obtain original allocation, laboratory and analyst roles and blinding procedures. |
| 18 |
Unverified |
Full text not readStored summary read |
N18 · Comparative efficacyIs the relationship between achieved exposure, weight or nutrient changes and PC effects directly verified?Required |
The original information that target and achieved average restriction differed is preserved. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. PC effects by achieved restriction, mechanisms and causal relationships with weight changes are not newly calculated or confirmed. |
Achieved restriction, adherence, concurrent changes and prespecified mediation or effects of interest |
Obtain original achieved exposure, adherence, concurrent changes, models and plans. |
| 19 |
Unverified |
Full text not readStored summary read |
N19 · Comparative efficacyDo gaps remain concerning post-intervention persistence, later measures and mechanisms?Required |
The original intervention lasted two years, and the stored summary has no quantitative post-intervention PC persistence effects. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. Post-intervention PC reductions, rebound or all-mechanism effects are not invented. |
Follow-up duration, measures, denominators, original effects and direct mechanism measurements |
Obtain direct post-intervention measures, models, denominators and follow-up material. |
| 20 |
Partly verified |
Full text not readStored summary read |
N20 · Comparative efficacyDo null PC findings establish null results for all clinical aging, disease or lifespan outcomes?Required |
The original account states that reduced disease, disability or death was not measured and healthy lifespan was not answered. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. Null PC findings are not recast as null clinical effects overall; the DunedinPACE signal is not recast as benefits for rejuvenation, lifespan or independent living. |
Direct clinical endpoints, follow-up, events, denominators and effects |
Direct events, long-term follow-up and original effects are needed for each clinical question. |
| 21 |
Partly verified |
Full text not readStored summary read |
N21 · Comparative efficacyAre the same CALERIE report, measures and time points kept from being counted as new independent replication?Required |
Both subclaim sheets share the same post hoc paper, 220 randomized participants and 197-person DNA data. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. Different measures, time points or sheets are not summed as independent trials or new participants. Final unique trial, participant and independent counts remain unrecorded. |
Relationships among the parent trial, post hoc report, same participants and sibling sheets |
Connect additional reports through original trial identifiers while retaining same-population relationships. |
| 22 |
Partly verified |
Full text not readStored summary read |
N22 · Comparative efficacyAre funding, DunedinPACE inventors and commercial licensing preserved alongside the PC findings?Required |
Support from NIA, American Brain Foundation, CIHR and others, authorship by DunedinPACE inventors D.L. Corcoran and D.W. Belsky, and commercial licensing are preserved. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. The same invention or licensing interests are not newly added for the PC measures. Product or service provision, employee affiliations and outside-analysis details have not been read. |
Funding, invention, licensing, affiliations, provision and analysis roles |
Obtain original funding, measure-related disclosures, affiliations, analysis and manuscript roles. |
| 23 |
Partly verified |
Full text not readStored summary read |
N23 · Supplementary harm evidenceAre absent safety reporting in this analysis and parent-trial harms separated?Required |
This post hoc analysis did not report safety as an endpoint, and original safety is Unknown. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. Null PC findings or positive DunedinPACE findings are not used as evidence of safety. They are not extended to absence of all harms in the parent CALERIE trial. |
Analysis-specific and parent-trial harm plans, collection, events by group and denominators |
Obtain original parent-trial harm collection, events, exposure, discontinuation and denominators. |
| 24 |
Unverified |
Full text not readStored summary read |
N24 · Supplementary harm evidenceWhat gaps concern achieved two-year exposure, rare harms, discontinuation and long-term follow-up?Required |
The original account explicitly states that this analysis cannot determine harms of long-term caloric restriction. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. Harm counts, rates, CIs or specific nutritional harms outside the original account are not invented. Null results for two measures are not assumed to mean no harms. |
Direct harms by group exposure, severity, discontinuation and duration |
Obtain original trial and follow-up harm, exposure, discontinuation and rare-event material. |
| 25 |
Unverified |
Full text not readStored summary read |
N25 · Supplementary harm evidenceAre harm replication, applicability and instructions for other populations or dietary exposures distinguished?Required |
The current material concerns historical two-year study conditions in healthy non-obese adults. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. Effects or harms for other populations or dietary methods are not newly confirmed; personal calorie, diet, weight-loss or treatment guidance is not created. |
Direct effects or harms and report relationships by population and exposure |
Connect direct comparison and harm material for new populations or exposures separately. |
| 26 |
Partly verified |
Full text not readStored summary read |
N26 · Comparative efficacyAre the stored summary and actual access to external abstracts, full text, registration and SAP distinguished?Required |
The original PubMed link and NCT00427193 are preserved, and the entire parent summary was read for production. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. A registration URL is not newly constructed, and all external materials remain unread. Separate links, screens and content review were not checked during original production. |
Original links, registration identifiers, preserved original material and material-specific access records |
Connect provided original material with its actual material-specific access status. |
| 27 |
Partly verified |
Full text not readStored summary read |
N27 · Comparative efficacyAre the reference date, Korean and English text, empty values, subclaim and parent values, and production status preserved?Supplementary |
The 2026-08-26 reference date, empty correction and deliberation values, Korean and English text, parent C54, original axes and subclaim D are preserved. Original pending and production-eligible markers are historical. |
Only the relevant information from the stored summary is recorded. Detailed original materials have not been read, and the original content review remains incomplete. The absent subclaim score is not filled in. The original content review remains incomplete; model, content and scope review activation and completion remain false, added assessment units are 0 and the final independent count is unrecorded. |
Distinction among original text, assessment records, dates, corrections, candidate history and review status |
Proposal: Reflect additional materials and decisions through preservation of original wording and separate events. |